MRes in Molecular Pathology, Bioinformatics & Diagnostics

Location: This course is highly flexible and delivered and examined as a distance learning programme and therefore can be campus free. For those wishing to attend a Nottingham campus, it would be delivered at the Medical School, QMC. Research projects can be undertaken at the Medical School QMC and City Hospital or another site with appropriate laboratory facilities

Course dates: Starting 23rd September 2019

Course fee: 2018/19 fees £10,710 Home/EU, £23,490 International (2019/20 yet to be published)

Target audience

Suitable for science graduates and medical graduates with an interest in molecular medicine including molecular oncology and cancer biology. For the medically qualified, the course is most suitable for those specialising in disciplines such as histopathology, oncology and clinical genetics. It is also suitable as an intercalated degree for medical students wishing to prepare themselves for the era of genomic medicine.


Faculty includes experts in

Genetics & Gene Regulation, Statistics & Bioinformatics & Diagnostics


The Molecular Pathology, Bioinformatics and Diagnostics MRes is for science and medical graduates. The curriculum, developed in collaboration with industry, is designed to open career pathways in academia, the health services and the biotechnology industry.



For science graduates (mainly in life sciences, genetics, biomedical sciences, pathology, biochemistry and microbiology), the course will:

  • provide training for a career in life sciences/allied disciplines (including the area of molecular diagnostics)
  • improve employability in the rapidly expanding market of molecular diagnostics
  • be a source of continuing professional development for persons already employed in the molecular diagnostics or biotechnology industry
  • be a firm foundation for NHS clinical scientists and biomedical staff in pathology to complete higher research training

The MRes in Molecular Pathology (180 credits) is a unique highly flexible programme with the taught component (60 credits) being delivered and assessed entirely as a distance learning programme whilst the research component (120 credits) is undertaken either within the University, industry or the NHS.

[Note: the 60 credits of taught modules are also available as a stand-alone PGCert for those who wish to undertake the taught component only.]

The extensive research project of 7 months will be undertaken in laboratories of repute within the Division of Cancer and Stem Cells, School of Medicine, and the Nottingham Molecular Pathology Node (NMPN). Some of the research projects may be collaborative placements in industry including research partners such as Source BioScience and Thermo Fisher Scientific. For such projects, there will be a named University supervisor and an industry based supervisor who will work in close collaboration.

How to apply

To apply for this course click here

Contact Us

University of Liverpool

Block A: Waterhouse Buildings

1-5 Brownlow Street

Liverpool L69 3GL



Follow us